Johnson & Johnson Stock Is Likely To See Higher Levels In The Near Term

The stock price of Johnson & Johnson has outperformed the broader indices over the last month or so. While the S&P500 index has seen a rise of 1% over the last one month, JNJ stock is up around 5%. This also compares with a 19% rise for its peer, Pfizer, a 3% rise for Bristol Myers Squibb, and…

About the Author

has written 23527 stories on this site.

Copyright © 2010 corporatecommunicationsnews101.com